Insider · CIK 0001873517
Pamela J. Cramer
officer
Files at RYTM (RHYTHM PHARMACEUTICALS, INC.). First filing Nov 8, 2024, latest Jul 29, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 9
$0 bought, $4.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RYTM: RHYTHM PHARMACEUTICALS, INC.
RYTMOct 9, 2026 · close 90.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | RHYTHM PHARMACEUTICALS, INC. | $131k 1,520 shares | -7% | +82% from low-6% from high | |
| 30Weak | RHYTHM PHARMACEUTICALS, INC. | $1.2M 15,572 shares | -45% | +90% from low0% from high | |
| 23Weak | RHYTHM PHARMACEUTICALS, INC. | $478k 7,031 shares | -27% | +45% from low0% from high | |
| 15Weak | RHYTHM PHARMACEUTICALS, INC. | $458k 7,031 shares | -27% | +39% from low-3% from high | |
| 33Weak | RHYTHM PHARMACEUTICALS, INC. | $1.2M 20,760 shares | -52% | +23% from low-14% from high | |
| 0Weak | RHYTHM PHARMACEUTICALS, INC. | $56k 982 shares | -5% | - | |
| 0Weak | RHYTHM PHARMACEUTICALS, INC. | $40k 701 shares | -4% | - | |
| 0Weak | RHYTHM PHARMACEUTICALS, INC. | $54k 902 shares | -6% | - | |
| 34Weak | RHYTHM PHARMACEUTICALS, INC. | $586k 9,375 shares | -52% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 26, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +3,125 | - | - | 22,334 | Jul 29, 2025 |
| Jul 29, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,520 | $85.93 | $131k | 20,814 | Jul 29, 2025 |
| Jul 26, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,125 | $0.00 | $0 | 0 | Jul 29, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +10,547 | $6.80 | $72k | 29,756 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +5,025 | $27.35 | $137k | 34,781 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,225 | $75.55 | $319k | 30,556 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7,831 | $76.69 | $601k | 22,725 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3,516 | $80.00 | $281k | 19,209 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -10,547 | $0.00 | $0 | 17,581 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -5,025 | $0.00 | $0 | 15,075 | Jul 11, 2025 |
| Jun 6, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +7,031 | $6.80 | $48k | 26,240 | Jun 10, 2025 |
| Jun 6, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7,031 | $68.05 | $478k | 19,209 | Jun 10, 2025 |
| Jun 6, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -7,031 | $0.00 | $0 | 28,128 | Jun 10, 2025 |
| Apr 29, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +7,031 | $6.80 | $48k | 26,240 | May 1, 2025 |
| Apr 29, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7,031 | $65.09 | $458k | 19,209 | May 1, 2025 |
| Apr 29, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -7,031 | $0.00 | $0 | 35,159 | May 1, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +14,060 | $6.80 | $96k | 33,269 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +6,700 | $27.35 | $183k | 39,969 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,430 | $58.36 | $375k | 33,539 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -600 | $59.00 | $35k | 32,939 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,700 | $60.00 | $402k | 26,239 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7,030 | $62.00 | $436k | 19,209 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | +14,060 | $0.00 | $0 | 42,190 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | +6,700 | $0.00 | $0 | 20,100 | Apr 10, 2025 |
| Feb 16, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +3,300 | - | - | 20,191 | Feb 19, 2025 |
| Feb 19, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -982 | $57.22 | $56k | 19,209 | Feb 19, 2025 |
| Feb 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative10b5-1 | +20,000 | $0.00 | $0 | 20,000 | Feb 19, 2025 |
| Feb 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Options (Right to Buy)derivative10b5-1 | +30,000 | $0.00 | $0 | 30,000 | Feb 19, 2025 |
| Feb 16, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,300 | $0.00 | $0 | 9,900 | Feb 19, 2025 |
| Feb 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +2,344 | - | - | 17,592 | Feb 11, 2025 |
| Feb 11, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -698 | $57.51 | $40k | 16,894 | Feb 11, 2025 |
| Feb 11, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3 | $57.54 | $173 | 16,891 | Feb 11, 2025 |
| Feb 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,344 | $0.00 | $0 | 2,343 | Feb 11, 2025 |
| Feb 1, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,650 | - | - | 16,150 | Feb 4, 2025 |
| Feb 4, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -902 | $59.43 | $54k | 15,248 | Feb 4, 2025 |
| Feb 1, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -2,650 | $0.00 | $0 | 5,300 | Feb 4, 2025 |
| Nov 6, 2024 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +4,687 | $19.02 | $89k | 18,187 | Nov 8, 2024 |
| Nov 6, 2024 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,687 | $60.00 | $281k | 13,500 | Nov 8, 2024 |
| Nov 7, 2024 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +4,688 | $19.02 | $89k | 18,188 | Nov 8, 2024 |
| Nov 7, 2024 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,688 | $65.00 | $305k | 13,500 | Nov 8, 2024 |
| Nov 6, 2024 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -4,687 | $0.00 | $0 | 18,750 | Nov 8, 2024 |
| Nov 7, 2024 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -4,688 | $0.00 | $0 | 14,062 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.